Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid - an intermediate for inhibitors of angiotensin converting enzyme

  • Schmidt E
  • Ghisalba O
  • Gygax D
 et al. 
  • 4


    Mendeley users who have this article in their library.
  • 30


    Citations of this article.


(R)-2-Hydroxy-4-phenylbutyric acid, an intermediate in the manufacture of inhibitors of angiotensin converting enzyme, can be produced continuously in an enzyme membrane reactor by enzymatic reduction of its corresponding α-keto acid. d-Lactate dehydrogenase (d-LDH) from Staphylococcus epidermidis was chosen as the most appropriate enzyme to carry out the NADH-dependent reduction. Formate dehydrogenase (FDH) was used for NADH regeneration. Detailed kinetic measurements and a mathematical model for the coupled enzyme reactions were applied to calculate the optimal conditions for continuous production of the α-hydroxy acid. A mass of 3.1 kg (R)-2-hydroxy-4-phenylbutyric acid was synthesized in a 220 ml enzyme membrane reactor over a period of 4 weeks. A mean space-time-yield of 165 g l-1d-1was achieved at low enzyme consumptions of 150 U kg-1α-hydroxy acid for FDH and d-LDH. © 1992.

Author-supplied keywords

  • (R)-2-hydroxy-4-phenylbutyric acid
  • Coenzyme regeneration
  • Enzyme membrane reactor
  • Staphylococcus epidermidis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Elke Schmidt

  • Oreste Ghisalba

  • Daniel Gygax

  • Gottfried Sedelmeier

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free